Synthesis and inflammatory response of a novel silk fibroin scaffold containing BMP7 adenovirus for bone regeneration

Bone

Volumn 51, Issue 4, 2012, Pages 704-713

  Zhang, Yufeng ^a   Wu, Chengtie ^a,b   Luo, Tao ^a   Li, Shue ^a   Cheng, Xiangrong ^a   Miron, Richard J ^a  

^a Wuhan University   (China)

^b SHANGHAI INSTITUTE OF CERAMICS   (China)

Author keywords

Biomedical applications; Biomimetics; Bone healing; Drug delivery; Medical applications

Indexed keywords

ADENOVIRUS VECTOR; ALIZARIN; INTERLEUKIN 2; INTERLEUKIN 6; OSTEOGENIC PROTEIN 1; SCAFFOLD PROTEIN; SILK FIBROIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMIMETICS; BONE REGENERATION; CALVARIA; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PROTEIN SECRETION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; SKULL DEFECT; SUSTAINED DRUG RELEASE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; BONE MORPHOGENETIC PROTEIN 7; BONE REGENERATION; CYTOKINES; FIBROINS; GENETIC VECTORS; MICE; MICROSCOPY, ELECTRON, SCANNING; REAL-TIME POLYMERASE CHAIN REACTION; SILK; TISSUE SCAFFOLDS;

EID: 84865631850     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.06.029     Document Type: Article

References (50)

1. Young C.S., Ladd P.A., Browning C.F., Thompson A., Bonomo J., Shockley K., et al. Release, biological potency, and biochemical integrity of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) combined with Augment(TM) Bone Graft or GEM 21S beta-tricalcium phosphate (beta-TCP). J Control Release Dec 16 2009, 140(3):250-255.
2. Park Y.J., Lee Y.M., Lee J.Y., Seol Y.J., Chung C.P., Lee S.J. Controlled release of platelet-derived growth factor-BB from chondroitin sulfate-chitosan sponge for guided bone regeneration. J Control Release Jul 3 2000, 67(2-3):385-394.
3. Wissink M.J., Beernink R., Poot A.A., Engbers G.H., Beugeling T., van Aken W.G., et al. Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices. J Control Release Feb 14 2000, 64(1-3):103-114.
4. Evans C. Gene therapy for the regeneration of bone. Injury Jun 2011, 42(6):599-604.
5. Wu G., Hunziker E.B., Zheng Y., Wismeijer D., Liu Y. Functionalization of deproteinized bovine bone with a coating-incorporated depot of BMP-2 renders the material efficiently osteoinductive and suppresses foreign-body reactivity. Bone Dec 2011, 49(6):1323-1330.
6. Kang S.W., Kim J.S., Park K.S., Cha B.H., Shim J.H., Kim J.Y., et al. Surface modification with fibrin/hyaluronic acid hydrogel on solid-free form-based scaffolds followed by BMP-2 loading to enhance bone regeneration. Bone Feb 2011, 48(2):298-306.
7. Miron R.J., Zhang Y.F. Osteoinduction: a review of old concepts with new standards. J Dent Res August 2012, 91(8):736-744.
8. Govender S., Csimma C., Genant H.K., Valentin-Opran A., Amit Y., Arbel R., et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am Dec 2002, 84-A(12):2123-2134.
9. Friedlaender G.E., Perry C.R., Cole J.D., Cook S.D., Cierny G., Muschler G.F., et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 2001, 83-A Suppl. 1(Pt 2):S151-158.
10. Valentin-Opran A., Wozney J., Csimma C., Lilly L., Riedel G.E. Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin Orthop Relat Res Feb 2002, 395:110-120.
11. Delgado J.J., Evora C., Sanchez E., Baro M., Delgado A. Validation of a method for non-invasive in vivo measurement of growth factor release from a local delivery system in bone. J Control Release Aug 28 2006, 114(2):223-229.
12. Oe S., Fukunaka Y., Hirose T., Yamaoka Y., Tabata Y. A trial on regeneration therapy of rat liver cirrhosis by controlled release of hepatocyte growth factor. J Control Release Mar 7 2003, 88(2):193-200.
13. Liao I.C., Chen S., Liu J.B., Leong K.W. Sustained viral gene delivery through core-shell fibers. J Control Release Oct 1 2009, 139(1):48-55.
14. Santos J.L., Oramas E., Pego A.P., Granja P.L., Tomas H. Osteogenic differentiation of mesenchymal stem cells using PAMAM dendrimers as gene delivery vectors. J Control Release Mar 4 2009, 134(2):141-148.
15. Guan M., Rodriguez-Madoz J.R., Alzuguren P., Gomar C., Kramer M.G., Kochanek S., et al. Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector. Cancer Res Feb 1 2006, 66(3):1620-1629.
16. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A Mar 3 1998, 95(5):2509-2514.
17. Toro H., Tang D.C., Suarez D.L., Sylte M.J., Pfeiffer J., Van Kampen K.R. Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector. Vaccine Apr 12 2007, 25(15):2886-2891.
18. Franceschi R.T. Biological approaches to bone regeneration by gene therapy. J Dent Res Dec 2005, 84(12):1093-1103.
19. Lattanzi W., Pola E., Pecorini G., Logroscino C.A., Robbins P.D. Gene therapy for in vivo bone formation: recent advances. Eur Rev Med Pharmacol Sci 2005, 9(3):167-174.
20. Rios H.F., Lin Z., Oh B., Park C.H., Giannobile W.V. Cell- and gene-based therapeutic strategies for periodontal regenerative medicine. J Periodontol 2011, 82(9):1223-1237.
21. Cho S.B., Miyaji F., Kokubo T., Nakamura T. Induction of bioactivity of a non-bioactive glass-ceramic by a chemical treatment. Biomaterials 1997, 18(22):1479-1485.
22. Sofia S., McCarthy M.B., Gronowicz G., Kaplan D.L. Functionalized silk-based biomaterials for bone formation. J Biomed Mater Res 2001, 54(1):139-148.
23. Zhang Y., Song J., Shi B., Wang Y., Chen X., Huang C., et al. Combination of scaffold and adenovirus vectors expressing bone morphogenetic protein-7 for alveolar bone regeneration at dental implant defects. Biomaterials 2007, 28(31):4635-4642.
24. Zhang Y., Fan W., Ma Z., Wu C., Fang W., Liu G., et al. The effects of pore architecture in silk fibroin scaffolds on the growth and differentiation of mesenchymal stem cells expressing BMP7. Acta Biomater 2010, 6(8):3021-3028.
25. Kokubo T., Takadama H. How useful is SBF in predicting in vivo bone bioactivity?. Biomaterials 2006, 27(15):2907-2915.
26. Zhang Y., Fan W., Ma Z., Wu C., Fang W., Liu G., et al. The effects of pore architecture in silk fibroin scaffolds on the growth and differentiation of mesenchymal stem cells expressing BMP7. Acta Biomater 2010, 6(8):3021-3028.
27. Gentleman E., Swain R.J., Evans N.D., Boonrungsiman S., Jell G., Ball M.D., et al. Comparative materials differences revealed in engineered bone as a function of cell-specific differentiation. Nat Mater 2009, 8(9):763-770.
28. Sawyer A.A., Song S.J., Susanto E., Chuan P., Lam C.X., Woodruff M.A., et al. The stimulation of healing within a rat calvarial defect by mPCL-TCP/collagen scaffolds loaded with rhBMP-2. Biomaterials 2009, 30(13):2479-2488.
29. Ebneter A., Casson R.J., Wood J.P., Chidlow G. Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury. Invest Ophthalmol Vis Sci 2010, 51(12):6448-6460.
30. Gugala Z., Olmsted-Davis E.A., Gannon F.H., Lindsey R.W., Davis A.R. Osteoinduction by ex vivo adenovirus-mediated BMP2 delivery is independent of cell type. Gene Ther 2003, 10(16):1289-1296.
31. Evans C.H., Ghivizzani S.C., Robbins P.D. Orthopedic gene therapy in 2008. Mol Ther 2009, 17(2):231-244.
32. Virk M.S., Conduah A., Park S.H., Liu N., Sugiyama O., Cuomo A., et al. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model. Bone 2008, 42(5):921-931.
33. Hsu W.K., Sugiyama O., Park S.H., Conduah A., Feeley B.T., Liu N.Q., et al. Lentiviral-mediated BMP-2 gene transfer enhances healing of segmental femoral defects in rats. Bone 2007, 40(4):931-938.
34. Betz O.B., Betz V.M., Nazarian A., Pilapil C.G., Vrahas M.S., Bouxsein M.L., et al. Direct percutaneous gene delivery to enhance healing of segmental bone defects. J Bone Joint Surg Am Feb 2006, 88(2):355-365.
35. Baltzer A.W., Lattermann C., Whalen J.D., Wooley P., Weiss K., Grimm M., et al. Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther May 2000, 7(9):734-739.
36. Menendez M.I., Clark D.J., Carlton M., Flanigan D.C., Jia G., Sammet S., et al. Direct delayed human adenoviral BMP-2 or BMP-6 gene therapy for bone and cartilage regeneration in a pony osteochondral model. Osteoarthritis Cartilage Aug 2011, 19(8):1066-1075.
37. Bertone A.L., Pittman D.D., Bouxsein M.L., Li J., Clancy B., Seeherman H.J. Adenoviral-mediated transfer of human BMP-6 gene accelerates healing in a rabbit ulnar osteotomy model. J Orthop Res Nov 2004, 22(6):1261-1270.
38. Egermann M., Schneider E., Evans C.H., Baltzer A.W. The potential of gene therapy for fracture healing in osteoporosis. Osteoporos Int Mar 2005, 16(Suppl. 2):S120-S128.
39. Egermann M., Baltzer A.W., Adamaszek S., Evans C., Robbins P., Schneider E., et al. Direct adenoviral transfer of bone morphogenetic protein-2 cDNA enhances fracture healing in osteoporotic sheep. Hum Gene Ther May 2006, 17(5):507-517.
40. Betz O.B., Betz V.M., Nazarian A., Egermann M., Gerstenfeld L.C., Einhorn T.A., et al. Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects. Gene Ther Jul 2007, 14(13):1039-1044.
41. Awad H.A., Zhang X., Reynolds D.G., Guldberg R.E., O'Keefe R.J., Schwarz E.M. Recent advances in gene delivery for structural bone allografts. Tissue Eng Aug 2007, 13(8):1973-1985.
42. Dupont K.M., Boerckel J.D., Stevens H.Y., Diab T., Kolambkar Y.M., Takahata M., et al. Synthetic scaffold coating with adeno-associated virus encoding BMP2 to promote endogenous bone repair. Cell Tissue Res Mar 2012, 347(3):575-588.
43. Lee H.H., Haleem A.M., Yao V., Li J., Xiao X., Chu C.R. Release of bioactive adeno-associated virus from fibrin scaffolds: effects of fibrin glue concentrations. Tissue Eng Part A Aug 2011, 17(15-16):1969-1978.
44. Zhang Y., Fan W., Nothdurft L., Wu C., Zhou Y., Crawford R., et al. In vitro and in vivo evaluation of adenovirus combined silk fibroin scaffolds for bone morphogenetic protein-7 gene delivery. Tissue Eng Part C Methods Aug 2011, 17(8):789-797.
45. Xu X.L., Tang T., Dai K., Zhu Z., Guo X.E., Yu C., et al. Immune response and effect of adenovirus-mediated human BMP-2 gene transfer on the repair of segmental tibial bone defects in goats. Acta Orthop Oct 2005, 76(5):637-646.
46. Cantrell D.A., Smith K.A. The interleukin-2 T-cell system: a new cell growth model. Science Jun 22 1984, 224(4655):1312-1316.
47. Kishimoto T. Interleukin-6: from basic science to medicine-40years in immunology. Annu Rev Immunol 2005, 23:1-21.
48. Broughton G., Janis J.E., Attinger C.E. The basic science of wound healing. Plast Reconstr Surg Jun 2006, 117(7 Suppl.):12S-34S.
49. Tanigawa K., Craig R.A., Stoolman L.M., Chang A.E. Effects of tumor necrosis factor-alpha on the in vitro maturation of tumor-reactive effector T cells. J Immunother Sep-Oct 2000, 23(5):528-535.
50. Brodbeck WG, Shive MS, Colton E, Ziats NP, Anderson JM. Interleukin-4 inhibits tumor necrosis factor-alpha-induced and spontaneous apoptosis of biomaterial-adherent macrophages. J Lab Clin Med Feb 2002;139(2):90-100.